Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustion
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustion ; volume:15 ; number:1 ; day:8 ; month:5 ; year:2024 ; pages:1-20 ; date:12.2024
Discover oncology ; 15, Heft 1 (8.5.2024), 1-20, 12.2024
- Creator
-
Liang, Hongxin
Zheng, Yong
Huang, Zekai
Dai, Jinchi
Yao, Lintong
Xie, Daipeng
Chen, Duo
Qiu, Hongrui
Wang, Huili
Li, Hao
Leng, Jinhang
Tang, Ziming
Zhang, Dongkun
Zhou, Haiyu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-024-00951-z
- URN
-
urn:nbn:de:101:1-2407172113183.619117939052
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liang, Hongxin
- Zheng, Yong
- Huang, Zekai
- Dai, Jinchi
- Yao, Lintong
- Xie, Daipeng
- Chen, Duo
- Qiu, Hongrui
- Wang, Huili
- Li, Hao
- Leng, Jinhang
- Tang, Ziming
- Zhang, Dongkun
- Zhou, Haiyu
- SpringerLink (Online service)
Other Objects (12)
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
Pan-cancer analysis of the prognostic and immunological role of PAQR4
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
The prognostic value and immunological role of CD44 in pan-cancer study
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
Pan-cancer analysis of the prognostic and immunological role of PAQR4
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
The prognostic value and immunological role of CD44 in pan-cancer study
Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker
Pan-cancer analysis of the prognostic and immunological role of PAQR4
MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
A comprehensive prognostic and immunological implications of PFKP in pan-cancer
Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarker
SLMO2 is a potential prognostic and immunological biomarker in human pan-cancer
Prognostic value and immunological role of PD-L1 gene in pan-cancer
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker
PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer